Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29


Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats.

He XH, Jordan CJ, Vemuri K, Bi GH, Zhan J, Gardner EL, Makriyannis A, Wang YL, Xi ZX.

Acta Pharmacol Sin. 2018 Jul 2. doi: 10.1038/s41401-018-0059-x. [Epub ahead of print]


CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.

Lugano R, Vemuri K, Yu D, Bergqvist M, Smits A, Essand M, Johansson S, Dejana E, Dimberg A.

J Clin Invest. 2018 Jun 25. pii: 97459. doi: 10.1172/JCI97459. [Epub ahead of print]


Age, pupil size differences, and color choices for the "dress" and the "jacket".

Vemuri K, Srivastava A, Agrawal S, Anand M.

J Opt Soc Am A Opt Image Sci Vis. 2018 Apr 1;35(4):B347-B355. doi: 10.1364/JOSAA.35.00B347.


Effects of Distal Mutations on the Structure, Dynamics and Catalysis of Human Monoacylglycerol Lipase.

Tyukhtenko S, Rajarshi G, Karageorgos I, Zvonok N, Gallagher ES, Huang H, Vemuri K, Hudgens JW, Ma X, Nasr ML, Pavlopoulos S, Makriyannis A.

Sci Rep. 2018 Jan 29;8(1):1719. doi: 10.1038/s41598-017-19135-7.


Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538.

Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J.

J Pharmacol Exp Ther. 2018 Mar;364(3):485-493. doi: 10.1124/jpet.117.245647. Epub 2018 Jan 8.


Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling.

Balla A, Dong B, Shilpa BM, Vemuri K, Makriyannis A, Pandey SC, Sershen H, Suckow RF, Vinod KY.

Neuropharmacology. 2018 Mar 15;131:200-208. doi: 10.1016/j.neuropharm.2017.10.040. Epub 2017 Nov 3.


CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats.

Wills KL, DeVuono MV, Limebeer CL, Vemuri K, Makriyannis A, Parker LA.

Behav Neurosci. 2017 Aug;131(4):304-11. doi: 10.1037/bne0000201.


Crystal structures of agonist-bound human cannabinoid receptor CB1.

Hua T, Vemuri K, Nikas SP, Laprairie RB, Wu Y, Qu L, Pu M, Korde A, Jiang S, Ho JH, Han GW, Ding K, Li X, Liu H, Hanson MA, Zhao S, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ.

Nature. 2017 Jul 27;547(7664):468-471. doi: 10.1038/nature23272. Epub 2017 Jul 5.


Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.

Barutta F, Grimaldi S, Gambino R, Vemuri K, Makriyannis A, Annaratone L, di Marzo V, Bruno G, Gruden G.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1655-1665. doi: 10.1093/ndt/gfx010.


Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric Analysis.

Mallipeddi S, Kreimer S, Zvonok N, Vemuri K, Karger BL, Ivanov AR, Makriyannis A.

J Proteome Res. 2017 Jul 7;16(7):2419-2428. doi: 10.1021/acs.jproteome.7b00023. Epub 2017 Jun 19.


Crystal Structure of the Human Cannabinoid Receptor CB1.

Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, Zhao S, Shui W, Li S, Korde A, Laprairie RB, Stahl EL, Ho JH, Zvonok N, Zhou H, Kufareva I, Wu B, Zhao Q, Hanson MA, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ.

Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004.


The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.

Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B.

Int J Neuropsychopharmacol. 2016 Dec 30;19(12). pii: pyw068. doi: 10.1093/ijnp/pyw068. Print 2016 Dec.


An approach towards a perfect thermal diffuser.

Vemuri KP, Bandaru PR.

Sci Rep. 2016 Jul 11;6:29649. doi: 10.1038/srep29649.


Do normal pupil diameter differences in the population underlie the color selection of #thedress?

Vemuri K, Bisla K, Mulpuru S, Varadharajan S.

J Opt Soc Am A Opt Image Sci Vis. 2016 Mar;33(3):A137-42. doi: 10.1364/JOSAA.33.00A137.


Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling.

Gueye AB, Trigo JM, Vemuri KV, Makriyannis A, Le Foll B.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):258-69. doi: 10.1097/FBP.0000000000000222.


Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.

Schindler CW, Redhi GH, Vemuri K, Makriyannis A, Le Foll B, Bergman J, Goldberg SR, Justinova Z.

Neuropsychopharmacology. 2016 Aug;41(9):2283-93. doi: 10.1038/npp.2016.27. Epub 2016 Feb 18.


Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1.

Bronova I, Smith B, Aydogan B, Weichselbaum RR, Vemuri K, Erdelyi K, Makriyannis A, Pacher P, Berdyshev EV.

Am J Respir Cell Mol Biol. 2015 Oct;53(4):555-62. doi: 10.1165/rcmb.2014-0331OC.


An Exploratory Investigation of Functional Network Connectivity of Empathy and Default Mode Networks in a Free-Viewing Task.

Vemuri K, Surampudi BR.

Brain Connect. 2015 Aug;5(6):384-400. doi: 10.1089/brain.2014.0260. Epub 2015 Jul 22.


Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.

Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU.

Psychopharmacology (Berl). 2015 Aug;232(15):2751-61. doi: 10.1007/s00213-015-3907-0. Epub 2015 Mar 15.


Evidence of stimulus correlated empathy modes--Group ICA of fMRI data.

Vemuri K, Surampudi BR.

Brain Cogn. 2015 Mar;94:32-43. doi: 10.1016/j.bandc.2014.12.006. Epub 2015 Jan 29.


Synthesis, characterization, molecular docking and anti-tubercular activity of Plumbagin-Isoniazid Analog and its β-cyclodextrin conjugate.

Dandawate P, Vemuri K, Venkateswara Swamy K, Khan EM, Sritharan M, Padhye S.

Bioorg Med Chem Lett. 2014 Nov 1;24(21):5070-5. doi: 10.1016/j.bmcl.2014.09.032. Epub 2014 Sep 21.


CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.

Wills KL, Vemuri K, Kalmar A, Lee A, Limebeer CL, Makriyannis A, Parker LA.

Psychopharmacology (Berl). 2014 Nov;231(22):4291-300. doi: 10.1007/s00213-014-3575-5. Epub 2014 Apr 27. Erratum in: Psychopharmacology (Berl). 2014 Nov;231(22):4419-20.


Synthesis, characterization and anti-tubercular activity of ferrocenyl hydrazones and their β-cyclodextrin conjugates.

Dandawate P, Vemuri K, Khan EM, Sritharan M, Padhye S.

Carbohydr Polym. 2014 Aug 8;108:135-44. doi: 10.1016/j.carbpol.2014.03.006. Epub 2014 Mar 19.


Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.

Rahn EJ, Deng L, Thakur GA, Vemuri K, Zvonok AM, Lai YY, Makriyannis A, Hohmann AG.

Mol Pain. 2014 Apr 18;10:27. doi: 10.1186/1744-8069-10-27.


Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach.

Le Foll B, Pushparaj A, Pryslawsky Y, Forget B, Vemuri K, Makriyannis A, Trigo JM.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:86-93. doi: 10.1016/j.pnpbp.2013.10.009. Epub 2013 Oct 17. Review.


Synthesis, characterisation and antitubercular activities of a series of pyruvate-containing aroylhydrazones and their Cu-complexes.

Jamadar A, Duhme-Klair AK, Vemuri K, Sritharan M, Dandawate P, Padhye S.

Dalton Trans. 2012 Aug 14;41(30):9192-201. doi: 10.1039/c2dt30322a. Epub 2012 Jun 21.


Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.

Yadlapalli RK, Chourasia OP, Vemuri K, Sritharan M, Perali RS.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2708-11. doi: 10.1016/j.bmcl.2012.02.101. Epub 2012 Mar 7.


Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.

Gamaleddin I, Wertheim C, Zhu AZ, Coen KM, Vemuri K, Makryannis A, Goldberg SR, Le Foll B.

Addict Biol. 2012 Jan;17(1):47-61. doi: 10.1111/j.1369-1600.2011.00314.x. Epub 2011 Apr 26.


Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties.

Bergman J, Delatte MS, Paronis CA, Vemuri K, Thakur GA, Makriyannis A.

Physiol Behav. 2008 Mar 18;93(4-5):666-70. Epub 2007 Nov 12. Review.

Supplemental Content

Loading ...
Support Center